Literature DB >> 19003407

New adenovirus vectors for protein production and gene transfer.

B Massie1, D D Mosser, M Koutroumanis, I Vitté-Mony, L Lamoureux, F Couture, L Paquet, C Guilbault, J Dionne, D Chahla, P Jolicoeur, Y Langelier.   

Abstract

Based on two new adenovirus expression cassettes, we have constructed a series of Ad transfer vectors for the overexpression of one or two genes either in a dicistronic configuration or with separate expression cassettes. Inclusion of the green or blue fluorescent protein in the vectors accelerates the generation of adenovirus recombinants and facilitates the functional characterization of genes both in vitro and in vivo by allowing easy quantification of gene transfer and expression. With our optimized tetracycline-regulated promoter (TR5) we have generated recombinant adenoviruses expressing proteins, that are either cytotoxic or which interfere with adenovirus replication, at levels of 10-15% of total cell protein. Proteins that are not cytotoxic can be produced at levels greater than 20% of total cell protein. As well, these levels of protein production can be achieved with or without adenovirus replication. This yield is similar to what can be obtained with our optimized human cytomegalovirus-immediate early promoter-enhancer (CMV5) for constitutive protein expression in non-complementing cell lines. Using the green fluorescent protein as a reporter, we have shown that a pAdCMV5-derived adenovirus vector expresses about 6-fold more protein in complementing 293 cells and about 12-fold more in non- complementing HeLa cells than an adenovirus vector containing the standard cytomegalovirus promoter. Moreover, a red-shifted variant of green fluorescent protein incorporated in one series of vectors was 12-fold more fluorescent than the S65T mutant, making the detection of the reporter protein possible at much lower levels of expression.

Entities:  

Year:  1998        PMID: 19003407      PMCID: PMC3449830          DOI: 10.1023/A:1008013211222

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  25 in total

1.  Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy.

Authors:  N Mittereder; K L March; B C Trapnell
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 2.  Regulation of apoptosis by viral gene products.

Authors:  J G Teodoro; P E Branton
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  The structural basis for spectral variations in green fluorescent protein.

Authors:  G J Palm; A Zdanov; G A Gaitanaris; R Stauber; G N Pavlakis; A Wlodawer
Journal:  Nat Struct Biol       Date:  1997-05

4.  Use of a dicistronic expression cassette encoding the green fluorescent protein for the screening and selection of cells expressing inducible gene products.

Authors:  D D Mosser; A W Caron; L Bourget; P Jolicoeur; B Massie
Journal:  Biotechniques       Date:  1997-01       Impact factor: 1.993

5.  Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression.

Authors:  S X Hu; W Ji; Y Zhou; C Logothetis; H J Xu
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

6.  Generation, validation, and large scale production of adenoviral recombinants with large size inserts such as a 6.3 kb human dystrophin cDNA.

Authors:  A Jani; H Lochmüller; G Acsadi; M Simoneau; J Huard; A Garnier; G Karpati; B Massie
Journal:  J Virol Methods       Date:  1997-03       Impact factor: 2.014

7.  Cloning and characterization of the human 5,10-methenyltetrahydrofolate synthetase-encoding cDNA.

Authors:  A Dayan; R Bertrand; M Beauchemin; D Chahla; A Mamo; M Filion; D Skup; B Massie; J Jolivet
Journal:  Gene       Date:  1995-11-20       Impact factor: 3.688

8.  Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells.

Authors:  A Garnier; J Côté; I Nadeau; A Kamen; B Massie
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

9.  Transcriptional activation by tetracyclines in mammalian cells.

Authors:  M Gossen; S Freundlieb; G Bender; G Müller; W Hillen; H Bujard
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

10.  A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity.

Authors:  G Acsadi; A Jani; B Massie; M Simoneau; P Holland; K Blaschuk; G Karpati
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

View more
  8 in total

1.  The chaperone function of hsp70 is required for protection against stress-induced apoptosis.

Authors:  D D Mosser; A W Caron; L Bourget; A B Meriin; M Y Sherman; R I Morimoto; B Massie
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

2.  Nuclear translocation controlled by alternatively spliced isoforms inactivates the QUAKING apoptotic inducer.

Authors:  J Pilotte; D Larocque; S Richard
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

3.  Hsp72-mediated suppression of c-Jun N-terminal kinase is implicated in development of tolerance to caspase-independent cell death.

Authors:  V L Gabai; J A Yaglom; V Volloch; A B Meriin; T Force; M Koutroumanis; B Massie; D D Mosser; M Y Sherman
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells.

Authors:  Yves Durocher; Sylvie Perret; Amine Kamen
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

5.  Virus-Like Particles Derived from HIV-1 for Delivery of Nuclear Proteins: Improvement of Production and Activity by Protein Engineering.

Authors:  Marc-André Robert; Viktoria Lytvyn; Francis Deforet; Rénald Gilbert; Bruno Gaillet
Journal:  Mol Biotechnol       Date:  2017-01       Impact factor: 2.695

6.  Production and Use of Gesicles for Nucleic Acid Delivery.

Authors:  Mathias Mangion; Marc-André Robert; Igor Slivac; Rénald Gilbert; Bruno Gaillet
Journal:  Mol Biotechnol       Date:  2021-10-01       Impact factor: 2.695

7.  The cumate gene-switch: a system for regulated expression in mammalian cells.

Authors:  Alaka Mullick; Yan Xu; René Warren; Maria Koutroumanis; Claire Guilbault; Sophie Broussau; Félix Malenfant; Lucie Bourget; Linda Lamoureux; Rita Lo; Antoine W Caron; Amelie Pilotte; Bernard Massie
Journal:  BMC Biotechnol       Date:  2006-11-03       Impact factor: 2.563

8.  HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity.

Authors:  Saravana Kanagavelu; James M Termini; Sachin Gupta; Francesca N Raffa; Katherine A Fuller; Yaelis Rivas; Sakhi Philip; Richard S Kornbluth; Geoffrey W Stone
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.